These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
583 related articles for article (PubMed ID: 17304350)
21. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease. Blair LJ; Sabbagh JJ; Dickey CA Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659 [TBL] [Abstract][Full Text] [Related]
22. Phosphorylated tau and the neurodegenerative foldopathies. Kosik KS; Shimura H Biochim Biophys Acta; 2005 Jan; 1739(2-3):298-310. PubMed ID: 15615647 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the tau-associated proteome reveals that exchange of Hsp70 for Hsp90 is involved in tau degradation. Thompson AD; Scaglione KM; Prensner J; Gillies AT; Chinnaiyan A; Paulson HL; Jinwal UK; Dickey CA; Gestwicki JE ACS Chem Biol; 2012 Oct; 7(10):1677-86. PubMed ID: 22769591 [TBL] [Abstract][Full Text] [Related]
24. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Connell P; Ballinger CA; Jiang J; Wu Y; Thompson LJ; Höhfeld J; Patterson C Nat Cell Biol; 2001 Jan; 3(1):93-6. PubMed ID: 11146632 [TBL] [Abstract][Full Text] [Related]
25. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau. Blair LJ; Nordhues BA; Hill SE; Scaglione KM; O'Leary JC; Fontaine SN; Breydo L; Zhang B; Li P; Wang L; Cotman C; Paulson HL; Muschol M; Uversky VN; Klengel T; Binder EB; Kayed R; Golde TE; Berchtold N; Dickey CA J Clin Invest; 2013 Oct; 123(10):4158-69. PubMed ID: 23999428 [TBL] [Abstract][Full Text] [Related]
26. Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies. Miyata Y; Koren J; Kiray J; Dickey CA; Gestwicki JE Future Med Chem; 2011 Sep; 3(12):1523-37. PubMed ID: 21882945 [TBL] [Abstract][Full Text] [Related]
28. The Crystal Structure of the Hsp90-LA1011 Complex and the Mechanism by Which LA1011 May Improve the Prognosis of Alzheimer's Disease. Roe SM; Török Z; McGown A; Horváth I; Spencer J; Pázmány T; Vigh L; Prodromou C Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509087 [TBL] [Abstract][Full Text] [Related]
29. Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes. Woo JA; Liu T; Zhao X; Trotter C; Yrigoin K; Cazzaro S; Narvaez E; Khan H; Witas R; Bukhari A; Makati K; Wang X; Dickey C; Kang DE Hum Mol Genet; 2017 Oct; 26(20):3973-3988. PubMed ID: 29016855 [TBL] [Abstract][Full Text] [Related]
30. Carboxyl terminus of hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90 kDa heat-shock protein (hsp90) in vitro. Morales JL; Perdew GH Biochemistry; 2007 Jan; 46(2):610-21. PubMed ID: 17209571 [TBL] [Abstract][Full Text] [Related]
31. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839 [TBL] [Abstract][Full Text] [Related]
32. Molecular chaperone-mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain. Sahara N; Maeda S; Yoshiike Y; Mizoroki T; Yamashita S; Murayama M; Park JM; Saito Y; Murayama S; Takashima A J Neurosci Res; 2007 Nov; 85(14):3098-108. PubMed ID: 17628496 [TBL] [Abstract][Full Text] [Related]
33. Identification of residues on Hsp70 and Hsp90 ubiquitinated by the cochaperone CHIP. Kundrat L; Regan L J Mol Biol; 2010 Jan; 395(3):587-94. PubMed ID: 19913553 [TBL] [Abstract][Full Text] [Related]
34. Chaperones increase association of tau protein with microtubules. Dou F; Netzer WJ; Tanemura K; Li F; Hartl FU; Takashima A; Gouras GK; Greengard P; Xu H Proc Natl Acad Sci U S A; 2003 Jan; 100(2):721-6. PubMed ID: 12522269 [TBL] [Abstract][Full Text] [Related]
35. A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer's mouse model via an HSF1-mediated mechanism. Wang B; Liu Y; Huang L; Chen J; Li JJ; Wang R; Kim E; Chen Y; Justicia C; Sakata K; Chen H; Planas A; Ostrom RS; Li W; Yang G; McDonald MP; Chen R; Heck DH; Liao FF Mol Psychiatry; 2017 Jul; 22(7):990-1001. PubMed ID: 27457810 [TBL] [Abstract][Full Text] [Related]
36. Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease. Liu D; Tang H; Li XY; Deng MF; Wei N; Wang X; Zhou YF; Wang DQ; Fu P; Wang JZ; Hébert SS; Chen JG; Lu Y; Zhu LQ Mol Ther; 2017 Mar; 25(3):752-764. PubMed ID: 28202389 [TBL] [Abstract][Full Text] [Related]
37. Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic Acid. Shan Y; Wang DD; Xu YX; Wang C; Cao L; Liu YS; Zhu CQ J Alzheimers Dis; 2016; 49(3):829-44. PubMed ID: 26577520 [TBL] [Abstract][Full Text] [Related]
38. Linking HSP90 target occupancy to HSP70 induction and efficacy in mouse brain. Thirstrup K; Sotty F; Montezinho LC; Badolo L; Thougaard A; Kristjánsson M; Jensen T; Watson S; Nielsen SM Pharmacol Res; 2016 Feb; 104():197-205. PubMed ID: 26731018 [TBL] [Abstract][Full Text] [Related]
39. Cereblon Regulates the Proteotoxicity of Tau by Tuning the Chaperone Activity of DNAJA1. Akber U; Jo H; Jeon S; Yang SJ; Bong S; Lim S; Kim YK; Park ZY; Park CS J Neurosci; 2021 Jun; 41(24):5138-5156. PubMed ID: 33972400 [TBL] [Abstract][Full Text] [Related]
40. Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein. Tortosa E; Santa-Maria I; Moreno F; Lim F; Perez M; Avila J J Alzheimers Dis; 2009; 17(2):319-25. PubMed ID: 19363271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]